| Mepha Pharma AG - Amlodipin-Valsartan-HCT-Mepha Teva 10 mg/160 mg/25 mg, Lactab | | 67228 | | 04 | | Amlodipin-Valsartan-HCT-Mepha Teva 10 mg/160 mg/25 mg | | Lactab | | C09DX01 | | Valsartan, Amlodipin und Hydrochlorthiazid | | 05.12.2019 | | |
| | Composition | | Filmtablette: amlodipinum 10 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, amylum pregelificatum, crospovidonum, carboxymethylamylum natricum A, natrium max. 0.294 mg, calcii hydrogenophosphas, silica colloidalis anhydrica, magnesii stearas, Überzug: lactosum monohydricum 5.4 mg, hypromellosum, macrogolum 4000, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. | informations additionels |
|---|
| Amlodipine | 10 mg | Filmtablette | | Hydrochlorothiazide | 25 mg | | | Valsartan | 160 mg | |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Amylum Pregelificatum | | | | Calcium Hydrogenophosphate | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Lactose Monohydrate | 5.4 mg | Überzug | | Macrogol | 4000 | | | Magnesii Stearas | | | | Sodium | 0.294 mg | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| Aucune entrée n'a été trouvée. |
|
|
